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Dear Editor,
Methadone is a drug associated with the development
of prolonged Correcred QT (QTc) interval, as QT inter-
val prolongation can occur in up to 15% of methadone-
maintenance patients. In recent years, methadone found
to be associated with an increased risk of sudden death
in a community-based study (1, 2). “Torsades de Pointes”
is a quick and dangerous rhythm that quickly becomes
ventricular fibrillation. If this rhythm is rapid or pro-
longed, it can lead to ventricular fibrillation or sudden
cardiac death. The usual clinical manifestations of TdP
are palpitations, dizziness, and syncope. It is certain that
no cardiac drugs are recognized to increase the propen-
sity for TdP. The most common risk factors of methadone-
associated QT prolongation and TdP include a high dose
of methadone or chronic use, old age, accompaniment
with enhancing drugs methadone levels, infections such
as AIDS, old age, low potassium, kidney failure, heart dis-
ease, female gender, and cirrhosis of the liver (3). Despite
the availability of methadone for over 60 years, only in the
past 10 years has this medication received attention for its
potential to cause QTc prolongation leading to Torsades de
Pointes (4-6).
We report 4 cases of methadone-induced Torsades de
pointes. Through rapid taper of methadone, the patient’s
ECG normalized.
Case 1: A 46 year-old man with a history of chronic
methadone therapy presented with syncope. He used
methadone, 15 cc/daily and increase to 20 cc/daily. The ini-
tial assessment includes a detailed history of heart disease
and blood sample. The patient was admitted to the cardiol-
ogy service for ECG monitoring. Shortly thereafter, the pa-
tient experienced frequent runs of non-sustained ventric-
ular tachycardia culminating in an episode of Torsades de
pointes. His methadone dose was reduced, followed. ECG
demonstrated a prolonged QTc interval of 570 millisec-
onds. In consultation with the psychiatrist, methadone
slowly stopped and at the time of discharge, the QTc in-
terval was normal (less than 450 milliseconds). Case 2:
A 59 year-old man to the cardiology service for recurrent
syncope. He had a history of 10 years of methadone ther-
apy, 70 mg methadone. In ECG monitoring, the patient
had a PVC bigeminy. His methadone dose was discon-
tinued; in the follow up, QTc interval was decreased. At
the time of discharge, the QTc interval was 420 millisec-
onds. Case 3: A 60 year-old man with a history of chronic
methadone therapy (15 cc/daily for ≥ 15 years) and an in-
crease in 3 months to 18 cc/day admit to the cardiology
service for syncope. In ECG monitoring, the patient had
a Torsades de pointes. In the follow up, after discontinu-
ing methadone, ECG demonstrated a prolonged QTc inter-
val of 720 milliseconds. In consultation with the psychia-
trist, methadone slowly stopped. At the time of discharge,
the QTc interval was 530 milliseconds. Lastly Case 4: A 37
year-old man with a history of 5 years methadone therapy
(10 cc/daily) for muscoskeletal pain and increased it to 20
cc/daily before admission to the cardiology service for syn-
cope. In ECG monitoring, the patient had a Torsades de
pointes. After laying ICD, the QTc interval was 320 millisec-
onds (Figure 1).
Our patient was receiving a normal dose of methadone
and had no other risk factors predisposing them to QTc
prolongation.
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Figure 1. ECG Torsades de Pointes
Due to unpredictable of QT prolongation and Torsades
de pointes in patients with high doses of opium and high
dependence who are taking high doses of methadone, al-
ternative agents such as buprenorphine and a mixed opi-
oid antagonist/agonist should be considered.
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